| 000 | 01790 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250514001626.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0031-1820 | ||
| 024 | 7 |
_a10.1017/s0031182000007423 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorton, J | |
| 245 | 0 | 0 |
_aAn analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. _h[electronic resource] |
| 260 |
_bParasitology _c2000 |
||
| 300 |
_aS147-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlbendazole _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiethylcarbamazine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aElephantiasis, Filarial _xdrug therapy |
| 650 | 0 | 4 |
_aFilaricides _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIvermectin _xtherapeutic use |
| 650 | 0 | 4 | _aNational Health Programs |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aWitt, C | |
| 700 | 1 | _aOttesen, E A | |
| 700 | 1 | _aLazdins, J K | |
| 700 | 1 | _aAddiss, D G | |
| 700 | 1 | _aAwadzi, K | |
| 700 | 1 | _aBeach, M J | |
| 700 | 1 | _aBelizario, V Y | |
| 700 | 1 | _aDunyo, S K | |
| 700 | 1 | _aEspinel, M | |
| 700 | 1 | _aGyapong, J O | |
| 700 | 1 | _aHossain, M | |
| 700 | 1 | _aIsmail, M M | |
| 700 | 1 | _aJayakody, R L | |
| 700 | 1 | _aLammie, P J | |
| 700 | 1 | _aMakunde, W | |
| 700 | 1 | _aRichard-Lenoble, D | |
| 700 | 1 | _aSelve, B | |
| 700 | 1 | _aShenoy, R K | |
| 700 | 1 | _aSimonsen, P E | |
| 700 | 1 | _aWamae, C N | |
| 700 | 1 | _aWeerasooriya, M V | |
| 773 | 0 |
_tParasitology _gvol. 121 Suppl _gp. S147-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/s0031182000007423 _zAvailable from publisher's website |
| 999 |
_c11317657 _d11317657 |
||